96
Participants
Start Date
April 5, 2023
Primary Completion Date
October 22, 2025
Study Completion Date
March 11, 2030
No treatment given
Participants will not receive any investigational treatment in this study.
NYU Langone Health, New York
NY Presbyt Hosp-W Cornell Med, New York
Joe C.Wen & Fam CTR for Adv Care, Irvine
Keio University Hospital, Shinjuku-ku, Tokyo
Neurologimottagningen Lund, Lund
Region Skane Skanes Universitetssjukhus, Lund
Clinical Neuroscience, Cambridge
Lead Sponsor
Novo Nordisk A/S
INDUSTRY